DCPLA-ME

• UNSPSC Description:

  DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases[1].

• Target Antigen:

  PKC

• Type:

  Reference compound

• Related Pathways:

  Epigenetics;TGF-beta/Smad

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/dcpla-me.html

• Purity:

  98.0

• Solubility:

  DMSO : 15.62 mg/mL (ultrasonic)

• Smiles:

  O=C(OC)CCCCCCCC1C(CC2C(CCCCC)C2)C1

• Molecular Weight:

  322.53

• References & Citations:

  [1]Thomas J. Nelson, et al. Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases. WO2015058191A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  56687-67-3